-
Americas
-
Asia & Oceania
-
A-I
J-Z
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Regions
-
Americas
-
Asia & Oceania
-
Europe
-
Middle East & Africa
-
Americas
-
Asia & Oceania
-
Europe
Europe
- Adriatic
- Belgium
- Bulgaria
- Czech Republic
- Deutschland
- España
- France
- Greece
- Hungary
- Ireland
- Israel
- Italia
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
SOLUTIONS
-
Research & Development
-
Real World Evidence
-
Commercialization
-
Safety & Regulatory Compliance
-
Technologies
LIFE SCIENCE SEGMENTS
HEALTHCARE SEGMENTS
- Information Partner Services
- Financial Institutions
- Public Health and Government
- Patient Associations
- Payers
- Providers
THERAPEUTIC AREAS
- Cardiovascular
- Cell and Gene Therapy
- Central Nervous System
- GI & Hepatology
- Infectious Diseases and Vaccines
- Oncology
- Pediatrics
- Rare Diseases
- View All
Impacting People's Lives
"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.
LEARN MORE
Harness the power to transform clinical development
Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.
Research & Development OverviewResearch & Development Quick Links
Real World Evidence. Real Confidence. Real Results.
Generate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.
REAL WORLD EVIDENCE OVERVIEWReal World Evidence Quick Links
See markets more clearly. Opportunities more often.
Elevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.
COMMERCIALIZATION OVERVIEWCommercialization Quick Links
Service driven. Tech-enabled. Integrated compliance.
Orchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.
COMPLIANCE OVERVIEWSafety & Regulatory Compliance Quick Links
Intelligence that transforms life sciences end-to-end.
When your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.
TECHNOLOGIES OVERVIEWTechnology Quick Links
CLINICAL PRODUCTS
COMMERCIAL PRODUCTS
COMPLIANCE, SAFETY, REG PRODUCTS
BLOGS, WHITE PAPERS & CASE STUDIES
Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTSTHE IQVIA INSTITUTE
An in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.
SEE LATEST REPORTS
FEATURED INNOVATIONS
-
Connected Intelligence
-
AI & Machine Learning
-
Human Data Science Cloud
-
IQVIA Innovation Hub
-
Decentralized Trials
-
Genomics
WHO WE ARE
- Our Story
- Our Impact
- Commitment to Public Health
- Code of Conduct
- Environmental Social Governance
- Privacy
- Executive Team
NEWS & RESOURCES
Unlock your potential to drive healthcare forward
By making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.
LEARN MORE
AI & Machine Learning with a healthcare IQ.
Artificial intelligence is accelerating opportunities. Realizing the benefits for healthcare requires the right expertise. Together, we can solve the problems of today, and drive the breakthroughs of tomorrow.
LEARN MORE
Your healthcare data deserves more than just a cloud.
The IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.
LEARN MORE
Innovations make an impact when bold ideas meet powerful partnerships
The IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.
LEARN MORE
Proven, faster DCT solutions
IQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.
LEARN MORE
Unlock the power of genomic research.
IQVIA enables genomic research via global access to a network of genomic-clinical data, proprietary technologies that enable federated analytics, and therapeutic area & bioinformatics expertise to help you answer your most pressing research questions.
LEARN MOREWORKING AT IQVIA
Our mission is to accelerate innovation for a healthier world. Together, we can solve customer challenges and improve patient lives.
LEARN MORELIFE AT IQVIA
Careers, culture and everything in between. Find out what’s going on right here, right now.
LEARN MORE
WE’RE HIRING
"Improving human health requires brave thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.
SEARCH JOBSNota de prensa
"El Cáncer No Espera": Casi un 20% de pacientes de cáncer no fueron diagnosticados durante el año 2020 en España
sept.
21,
2021
En el marco del encuentro “El Cáncer No Espera”, organizado por IQVIA y que ha contado con algunos de los profesionales más relevantes del área de oncología en nuestro país, cabe destacar algunas conclusiones que ponen en relieve la necesidad de retomar el normal funcionamiento del sistema sanitario para garantizar el tratamiento a sus pacientes.
Este encuentro, que tiene su origen en la divulgación del White Paper “Cancer Won’t Wait” desarrollado por el IQVIA Institute, ha considerado los diferentes players implicados, desde las farmacias locales hasta las organizaciones -nacionales e internacionales- y sus funciones, así como la colaboración y cooperación entre las distintas partes interesadas. El informe concluye que el cáncer pronto se convertirá en una emergencia, como lo ha sido la pandemia. Si no damos pronto con los pacientes aún no diagnosticados por la pandemia, entonces el sistema sanitario se enfrentará a pacientes que debuten con una enfermedad más avanzada y/o con peor estado de salud.
En nuestro país existen indicadores suficientes de que los diagnósticos están por debajo sobre lo que deberían ser y que se espera que, además, haya más personas diagnosticadas en estadio avanzado, incluso metastásico, y muchos ni siquiera lleguen a recibir tratamiento. En España las cirugías programadas de estos pacientes oncológicos que no se llevaron a cabo ascienden a más de 31.000 en nuestro país frente a datos del 2019.
El Ministerio de Sanidad español publicó en febrero de 2021 algunas iniciativas para afrontar el reto que ha supuesto la pandemia y garantizar un sistema sostenible a largo plazo y que pretenden mejorar la eficiencia del sistema sanitario centrándose en maximizar el uso de los recursos y garantizar al máximo la continuidad de los servicios sanitarios y la investigación clínica.
Isabel Ricote, manager de oncología en IQVIA, destacó que “según fuentes internas disponibles en IQVIA, se estima que desde el inicio de la pandemia COVID se han diagnosticado 62.000 pacientes oncológicos menos de lo esperado según referencia de 2019. Esto tendrá claras consecuencias tanto en la supervivencia a medio y largo plazo, como en el aumento de la complejidad del manejo terapéutico de estos pacientes.»
Durante la mesa redonda celebrada durante el encuentro, Mariluz Amador, directora médica de la AECC, señaló que “es prioritario animar a la gente a que acuda a la consulta ante la aparición de síntomas, ya que muchos indicadores confirman que muchos pacientes no acuden a consulta por miedo a la COVID-19, incluso una vez pasado el colapso del sistema”.
Poner en valor la farmacia, acompañar al paciente no solo durante la pandemia sino durante toda la enfermedad y en cualquier circunstancia, establecer una estrategia paralela a la COVID en el sistema de salud para no afectar al paciente oncológico, y abordar una clínica oncológica normal y no de emergencia, son algunas de las conclusiones más relevantes que se han abordado en la mesa redonda.